AzTrials
AzTrials

IBDPEARLNCT06860009

Psychological Intervention for Fatigue in Inflammatory Bowel Diseases

A study testing Multicomponent psychological intervention, Early start and Late start (after 28 weeks) in people with IBD and Crohn's Diseases, run by Universitaire Ziekenhuizen KU Leuven.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

The investigators would like to evaluate the effect of a multicomponent psychological treatment on fatigue as a symptom of patients with inflammatory bowel diseases (IBD). The intervention will be a combined program consisting of a psychological intervention (Acceptance and Commitment Therapy) and a behavioral… Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
IBD, Crohn's Diseases, Ulcerative Colitis (UC)
What is being tested?
Multicomponent psychological intervention, Early start and Late start (after 28 weeks)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
155 participants
Where
No sites listed yet
Study dates
1 Sep 2025to 30 Oct 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
  • Males and females 18-70 years old.
  • Patients with a diagnosis of ulcerative colitis (UC), Crohn's disease (CD), inflammatory bowel disease type unclassified (IBDU) based on radiology, endoscopy and/or histology
  • Patients with a disease duration of more than one year
  • Patients with a score of <30 on the FACIT Fatigue scale
  • Patients possessing a smartphone
  • Patients with an availability to commit to daily behavioural changes
  • Patients being fluent in Dutch.

Who cannot join

  • Patients that initiated new IBD medication (steroids, mesalamine, thiopurines, methotrexate, biologicals or small molecules) in the past three months prior to screening
  • Patients with objective signs of active disease (CRP<10mg/L or faecal calprotectin <250µg/g) at screening
  • Participation in an interventional Study with an investigational medicinal product (IMP) or device at screening
  • Patients with planned surgery at screening
  • Patients with an iron (<65 µg/dL), vitamin D (<11 µg/L), vitamin B12 (<197 ng/L) or folic acid (<3.9 µg/L) deficiency or malnutrition (weight loss >10-15% within six months, BMI <18.5 kg/m², NRS >5 or serum albumin <30 g/L) at screening
  • Patients with thyroid dysfunction or hypophosphatemia at screening
Show all 11Show fewer
  • Patients with physical injury (according to researcher's interpretation) at screening
  • Patients with self-reported sleep disturbance or periods of apnoea at screening
  • Patients with BMI >30 kg/m² at screening
  • Patients with present or past diagnosis of severe psychiatric disease diagnosis (ongoing major depression, schizophrenia, bipolar disease, ongoing substance abuse) at screening
  • Patients that initiated new psychotropic medication or had a changed dosage of psychotropic medication in the past three months prior to screening

About this study

Official title: Psychological Intervention for Fatigue in Inflammatory Bowel Diseases: a Randomized Controlled Trial

The investigators would like to evaluate the effect of a multicomponent psychological treatment on fatigue as a symptom of patients with inflammatory bowel diseases (IBD). The intervention will be a combined program consisting of a psychological intervention (Acceptance and Commitment Therapy) and a behavioral intervention (implementation of frequent short naps and graded increase of physical activity). Next to the hypothesized effect on fatigue, the investigators will also measure the effect on fatigability, IBD related disability, anxiety, depression, stress, disease acceptance and perceived control as well as (biomarkers of) disease activity.

Read the detailed description

Ulcerative colitis (UC) and Crohn's disease (CD) are chronic inflammatory bowel diseases that significantly impact patients' quality of life. One of the most prevalent and distressing symptoms associated with both UC and CD is fatigue, which can arise from both the physiological effects of the diseases and the psychological burden of living with a chronic condition. Despite the importance of addressing fatigue, traditional treatment approaches often focus primarily on physical symptoms, neglecting the multifaceted nature of fatigue that includes emotional and lifestyle factors.

This research aims to evaluate a novel multicomponent intervention that combines Acceptance and Commitment Therapy (ACT), frequent napping, and Graded Activity. Each component targets different dimensions of fatigue:

Acceptance and Commitment Therapy (ACT): ACT is a mindfulness-based therapeutic approach that encourages individuals to accept their thoughts and feelings rather than fighting against them. It promotes psychological flexibility and helps individuals commit to actions aligned with their values, even in the presence of discomfort. Previous studies have demonstrated ACT's effectiveness in managing chronic pain, anxiety, and other health-related issues, suggesting its potential benefit in addressing fatigue in chronic conditions like UC and CD.

Frequent Napping: Napping has been shown to help mitigate daytime fatigue, improve alertness, and enhance overall well-being. For patients with UC and CD, who often experience irregular sleep patterns due to their symptoms, implementing structured napping could serve as a valuable strategy for managing fatigue. However, this may be less suitable for patients working fulltime.

Graded Activity: Graded Activity is a structured approach to increase physical activity gradually. It involves setting achievable goals and progressively increasing activity levels, which can help mitigate fatigue and improve overall physical functioning. In the context of UC and CD, where patients may experience cycles of flare-ups and remission, Graded Activity can provide a tailored strategy to reintroduce physical activity safely and effectively.

The rationale for combining these three interventions lies in their complementary nature. While ACT addresses the psychological and emotional aspects of fatigue, frequent napping provides immediate relief and recovery opportunities. Graded Activity contributes a structured method for increasing physical activity, helping patients regain their strength and stamina over time. Together, these components create a comprehensive framework that addresses fatigue from multiple angles, which is essential given the complex interplay of physical, emotional, and behavioral factors in both UC and CD.

This research has the potential to make significant contributions to the management of fatigue in patients with UC and CD. By integrating psychological, physiological, and behavioral strategies, the multicomponent intervention could offer a holistic approach that enhances patient care. The findings could inform clinical practice, paving the way for more tailored, multidisciplinary interventions that address the diverse needs of individuals with chronic illnesses.

In conclusion, this study seeks to bridge the gap in existing research by exploring the combined effects of ACT, frequent napping, and Graded Activity on fatigue in patients with UC and CD. The results could lead to improved therapeutic strategies, ultimately enhancing the quality of life and well-being of those living with these challenging conditions.

Patient (eligibility criteria) Inclusion criteria are being at least 18 years and younger than 70 years of age, a diagnosis of CD, UC or IBD type unclassified (IBDU), more than one year of follow-up since diagnosis, no new IBD medication (mesalamine, steroids, thiopurines, methotrexate, biologicals or small molecules) in the past three months prior to baseline, no objective signs of active disease (CRP <10 mg/L AND faecal calprotectin <250 µg/g), a score of <30 on the FACIT Fatigue scale, no planned surgery during the study, no iron (<65 µg/dL), vitamin D (<11 µg/L) , vitamin B12 (<197 ng/L) or folic acid (<3.9 µg/L) deficiency or malnutrition (weight loss >10-15% within six months, BMI <18.5 kg/m², NRS >5 and serum albumin <30 g/L) , no BMI >30 kg/m², no thyroid dysfunction, no hypophosphatemia (<0.64 mmol/L), no physical injury (according to researcher's interpretation), no self-reported sleep disturbance or apnea diagnosis, no present or past severe psychiatric disease diagnosis (ongoing major depression, schizophrenia, bipolar disease, ongoing substance abuse), no new psychotropic medication or change of dosage in the past three months prior to baseline, possessing a smartphone, availability to commit to daily behavioral changes, and being fluent in Dutch. Furthermore, patients will be asked to sign an informed consent.

Intervention The intervention is a combined program incorporating ACT alongside a behavioral approach that emphasizes frequent napping and a gradual increase in physical activity.

ACT is a psychological approach focused on accepting aspects beyond personal control while committing to actions that enhance and enrich one's life. This therapy utilizes strategies of acceptance and mindfulness, combined with commitment and behavior change techniques, to foster psychological flexibility. Key processes in ACT include acceptance, cognitive defusion, committed action, present-moment awareness, self-as-context, and values. The program will be specifically tailored to address fatigue related to IBD and will consist of eight weekly one-hour individual sessions.

  1. Introduction to ACT: Overview of ACT principles, emphasizing mindfulness and acceptance in the context of IBD fatigue.
  2. Understanding Fatigue: Exploration of the individual's experience with fatigue, including its impact on daily life and emotional well-being.
  3. Mindfulness Skills: Teaching mindfulness techniques to help individuals stay present and manage fatigue-related thoughts and feelings.
  4. Values Clarification: Identifying personal values and goals to enhance motivation and provide direction despite fatigue.
  5. Acceptance Techniques: Learning to accept the reality of fatigue rather than struggling against it, fostering a compassionate attitude toward oneself.
  6. Cognitive Defusion: Strategies to create distance from unhelpful thoughts related to fatigue, reducing their impact.
  7. Behavioral Activation: Developing a plan for gradually engaging in valued activities, tailored to energy levels and limitations.
  8. Review and Future Planning: Reflecting on progress, reinforcing skills learned, and creating a long-term strategy for managing fatigue and maintaining well-being.

After four weeks, participants will begin a personalized exercise regimen that includes frequent naps and gradually increasing activity levels. Participants will be encouraged to take two to five naps (depending on fatigue severity), each lasting 15 to 20 minutes, interspersed with active periods. "Active" refers to any non-resting or non-sleeping activity, which means that reading or watching TV is also considered active. Provided the participant reports an increase in energy, the amount of naps can be tapered off, while nap durations always remain consistent.

To establish a baseline for the graded activity program, participants will record their walking (or cycling, based on their preference) over five days (not necessarily consecutive), noting the duration each day until significant pain, fatigue, or shortness of breath occurs. This will help determine the maximum time at five different points. The average of these measurements will inform the initial activity level. In the first week of the intervention, participants will engage in walking three times at 80% of the average time achieved. Afterward, activity time will increase by 10-15% weekly. For those accustomed to regular exercise, running may replace walking or cycling, following the same protocol.

The overall intervention will span 14 weeks. Following the eight ACT sessions, participants will have two-weekly individual follow-up consultations with an IBD psychologist for ongoing support regarding napping and graded activity.

For data collection, participants will wear a smartwatch to track their activity levels. This data will serve solely as a measurement tool for researchers, and participants will not have access to their own activity data.

Comparison This study will be a prospective, randomized-controlled, monocentric, superiority trial utilizing a waiting list with a treatment-as-usual control arm. Half of the participants will start with the psychological intervention immediately (early intervention group), while the other half will wait six months before starting the intervention (late intervention or control group).

Outcome The primary endpoint is the percentage of participants achieving a ≥20% improvement on the FACIT Fatigue Scale (indicating reduced fatigue) between baseline and week 14. The FACIT Fatigue Scale is a brief 13-item tool that evaluates fatigue experienced during daily activities over the past week. Fatigue is rated on a four-point Likert scale (4 = not at all fatigued to 0 = very fatigued). Total scores range from 0 to 52, with lower scores indicating higher fatigue levels.

Being tested
Multicomponent psychological intervention, Early start, Late start (after 28 weeks)
Keywords
fatigue, IBD
Medical subject headings
Colitis, Ulcerative, Fatigue

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Multicomponent psychological interventionBehavioural

    The multicomponent intervention starts with 8 sessions of ACT (Acceptance and commitment therapy) once a week. After four weeks, patients start with graded activity and frequent napping. After eight weeks in the intervention period, patients will have consults with an IBD psychologist every two weeks. The intervention period is 14 weeks in total.

  • Early startBehavioural

    Patients in the early group immediately start with the multicomponent psychological intervention

  • Late start (after 28 weeks)Behavioural

    Patients in the late intervention group will wait 28 weeks before starting the intervention

Study groups in NCT06860009
Study groupRoleWhat they receive
Early intervention groupOtherGroup starts immediately with the 14-week intervention
Receives: Behavioral: Multicomponent psychological intervention; Behavioral: Early start
Late intervention groupOtherGroup starts with 14-week intervention after 28 weeks
Receives: Behavioral: Multicomponent psychological intervention; Behavioral: Late start (after 28 weeks)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. FACIT fatigue scale

    The percentage of participants achieving a ≥20% improvement on the Functional Assessment of Chronic Illness Therapy (FACIT) Fatigue Scale (indicating reduced fatigue) between baseline and week 14.

    Measured: 14 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Mar 2025
  2. Study start1 Sep 2025 (estimated)
  3. Primary completion2 Sep 2027 (estimated)
  4. Study completion30 Oct 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Patients will be randomized in early or late intervention group. The early intervention group immediately start with the intervention, while the late intervention group will wait until week 28 to start with the 14 week intervention.
Masking
None (open label)
Enrolment
155 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06860009
Sponsor's protocol ID
PEARL
Acronym
PEARL
Status last verified
Mar 2025
First submitted
27 Feb 2025
Last updated
10 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Multicomponent psychological intervention, Early start and Late start (after 28 weeks) in people with IBD and Crohn&#39;s Diseases, run by Universitaire Ziekenhuizen KU Leuven.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 10 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

FACIT fatigue scale (time frame: 14 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in